Restricted accessLetterFirst published online 2020-9
Exploration of an Association Between UFH Dosing Based on Estimated Blood Volume and Venous Thromboembolism and Bleeding in the Underweight and Critically Ill
CarterCBushwitzJGowanM, et al. Clinical experience with pharmacological venous thromboembolism prophylaxis in the underweight and critically ill. Ann Pharmacother. 2016;50:832-839. doi:10.1177/1060028016657347
2.
GilletteMAFranckAReederDN, et al. Unfractionated heparin anticoagulation using estimated blood volume based dosing versus weight-based dosing in a Veteran population. Am J Health Syst Pharm. 2015;72(23, suppl 3):S171-S176. doi:10.2146/sp150027
3.
NadlerSBHidalgoJUBlochT. Prediction of blood volume in normal human adults. Surgery. 1962;51:224-232.
4.
Lovenox [package insert].Bridgewater, NJ: Sanofi-Aventis US LLC; 2019.
5.
PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group; CookDMeadeM, et al. Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med. 2011;364:1305-1314. doi:10.1056/NEJMoa1014475
